Wednesday
May252011
Adding TEVA Pharmaceuticals to My Portfolios at Kapitall
May 25, 2011 at 10:15 AM 
I used the market pullback over the last couple days to add the pharmaceutical company TEVA (TEVA $49.22) to my portfolios. They have a good generic drug business which ads stability. With a POP (forward price earnings ratio) of 9 and a dividend yield of 1.6%, the company is also attractively valued.
I think the entire pharmaceutical sector offers a compelling value opportunity.